Liquidia Technologies

Yahoo Finance • 6 days ago

Is it a Wise Move to Buy Liquidia Corp. (LQDA) Shares?

Arquitos Capital Management, an investment management firm, released its second-quarter 2025 investor letter. During the period, the fund delivered a net return of 13.1%, bringing year-to-date gains to an impressive 28.8% as of June 30, 20... Full story

Yahoo Finance • 16 days ago

SA Asks: Which biotechs could be acquired by year's end?

[word m and a made with wood building blocks, stock image] Maksim Labkouski The fourth quarter has historically been a busy time for the biopharma industry, with the sector generally seeing a significant uptick in M&A activity. We asked... Full story

Yahoo Finance • 27 days ago

Why United Therapeutics Catapulted 38%, Pulling Insmed, Liquidia With It

United Therapeutics stock catapulted Tuesday, pulling shares of rivals Insmed and Liquidia higher, on positive test results in IPF. Continue Reading View Comments... Full story

Yahoo Finance • last month

Liquidia Corporation to Present at the 2025 Wells Fargo Healthcare Conference

MORRISVILLE, N.C., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) announced today that members of the company’s executive leadership team will be providing an update on the company's business during a fireside chat... Full story

Yahoo Finance • 2 months ago

Liquidia (LQDA) Climbs 13.68% as Yutrepia Prescriptions Surge

We recently published 10 Stocks on Euphoria. Are You Holding Any? Liquidia Corp. (NASDAQ:LQDA) is one of the best-performing stocks on Tuesday. Liquidia rallied for a third straight day on Tuesday, ending 13.68 percent higher at $24.10 as... Full story

Yahoo Finance • 2 months ago

Liquidia GAAP EPS of -$0.49 misses by $0.06, revenue of $8.84M beats by $4.95M

* Liquidia press release [https://seekingalpha.com/pr/20197076-liquidia-corporation-reports-second-quarter-2025-financial-results-and-provides-corporate] (NASDAQ:LQDA [https://seekingalpha.com/symbol/LQDA]): Q2 GAAP EPS of -$0.49 misses... Full story

Yahoo Finance • 2 months ago

Liquidia Corporation Reports Second Quarter 2025 Financial Results and Provides Corporate Update

YUTREPIA™ surpasses 900 unique patient prescriptions and 550 patient starts within 11 weeks after approval to treat PAH and PH-ILDPositive interim data from ASCENT trial reinforces YUTREPIA’s tolerability and efficacy profile in PH-ILD wit... Full story

Yahoo Finance • 2 months ago

Liquidia  Q2 2025 Earnings Preview

* Liquidia (NASDAQ:LQDA [https://seekingalpha.com/symbol/LQDA]) is scheduled to announce Q2 earnings results on Tuesday, August 12th, before market open. The consensus EPS Estimate is -$0.39 [https://seekingalpha.com/symbol/LQDA/earning... Full story

Yahoo Finance • 2 months ago

Liquidia Corporation to Report Second Quarter 2025 Financial Results on August 12, 2025

MORRISVILLE, N.C., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease, announced today that it will report its... Full story

Yahoo Finance • 2 months ago

United Therapeutics EVP Mahon sells $3.3m in shares

Paul A. Mahon, Executive Vice President and General Counsel at United Therapeutics Corp (NASDAQ:UTHR), sold 11,000 shares of common stock on July 24, 2025, according to a Form 4 filing with the Securities and Exchange Commission. The sal... Full story

Yahoo Finance • 2 months ago

Interesting LQDA Call Options For September 19th

Investors in Liquidia Corp (Symbol: LQDA) saw new options become available today, for the September 19th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the LQDA options chain for the new September 19t... Full story

Yahoo Finance • 3 months ago

Liquidia Corp: chief human resource officer Krepp sells $38k in stock

Liquidia Corp (NASDAQ:LQDA), a $1.24 billion market cap biotech company, saw its Chief Human Resource Officer Sarah Krepp sell 2,673 shares of common stock on July 14, 2025, at a price of $14.28, for a total transaction value of $38,170. T... Full story

Yahoo Finance • 3 months ago

Liquidia Receives $50M from HCRx, Accelerates YUTREPIA’s Commercial Launch Following Favorable Court Ruling

Liquidia Corporation (NASDAQ:LQDA) is one of the best low priced pharma stocks to buy now. On June 24, Liquidia announced the receipt of an additional $50 million from Healthcare Royalty/HCRx. The funding followed the US District Court for... Full story

Yahoo Finance • 3 months ago

Liquidia appoints Dana Boyle as chief accounting officer

Liquidia Corporation (NASDAQ:LQDA), a biopharmaceutical company with a current market capitalization of $1.03 billion, announced Monday that its board of directors has appointed Dana Boyle as chief accounting officer, effective the same da... Full story

Yahoo Finance • 3 months ago

Oversold Conditions For Liquidia (LQDA)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the R... Full story

Yahoo Finance • 3 months ago

United Therapeutics EVP Mahon sells $3.14 million in UTHR stock

Paul A. Mahon, Executive Vice President and General Counsel at United Therapeutics Corp (NASDAQ:UTHR), a $12.76 billion market cap company with impressive gross profit margins of 89%, sold 11,490 shares of common stock on June 26, 2025,... Full story

Yahoo Finance • 3 months ago

Nilda Mesa, United Therapeutics director, sells $187k in stock

Nilda Mesa, a director at UNITED THERAPEUTICS (NASDAQ:UTHR), sold 645 shares of common stock on June 24, 2025. The shares were sold at a weighted average price of $289.9926, for a total transaction value of $187,045. The $12.87 billion bio... Full story

Yahoo Finance • 3 months ago

Liquidia Receives $50 Million from Healthcare Royalty (HCRx) Following First Commercial Sale of YUTREPIA™

MORRISVILLE, N.C., June 23, 2025 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease, today announced the receipt of an addit... Full story

Yahoo Finance • 4 months ago

Noteworthy Tuesday Option Activity: LQDA, SWBI, MATX

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Liquidia Corp (Symbol: LQDA), where a total of 20,451 contracts have traded so far, representing approximately 2.0 million underly... Full story

Yahoo Finance • 4 months ago

Liquidia Schedules First Commercial Shipment of YUTREPIA™ (treprostinil) Inhalation Powder for Patients with PAH and PH-ILD

YUTREPIA now available to be prescribed to patients via specialty pharmaciesFDA approved YUTREPIA on May 23, 2025Court denies United Therapeutics’ request for preliminary injunction and a temporary restraining order, clearing the path for... Full story